Overview
Clinical Benefits
- Boosts T-cell immunity
- Antiviral properties
- Reduces chronic inflammation
- Supports immune recovery
Administration
Subcutaneous injection
Drug class: thymic peptide
Clinical Dosing
Typical dosage
1.6mg
Starting dose
0.8mg
Cadence
2x weekly
Full titration schedule
| Phase | Dose |
|---|---|
| Weeks 1-2 | 0.8mg twice weekly |
| Weeks 3+ | 1.6mg twice weekly |
Safety Profile
Side effects
- • Injection site redness
- • Fatigue (temporary)
Contraindications
- • Organ transplant recipients
- • Autoimmune conditions (use with caution)
Featured in these stacks
Stack 05
Elite DirectThe Fountain of Youth
Reverse the cellular clock
Thymosin Alpha-1 — immune modulation, restores thymic-mediated longevity signaling.
View stack
Stack 07
Elite DirectPrime Endocrine Reset
Recalibrate the endocrine axis
Thymosin Alpha-1 — restores thymic-immune signaling that flexes with the HPG axis.
View stack
Frequently asked questions
Thymosin Alpha-1 is most commonly researched for: Boosts T-cell immunity, Antiviral properties, Reduces chronic inflammation, Supports immune recovery.
Ready to build a protocol with Thymosin Alpha-1?
LIA, our clinical reasoning engine, will build a personalized protocol — dosing, cadence, cycling, and safety checks — tailored to your goals and intake.
You’ll be asked to sign in first. Free tier includes the chat preview.
Information on this page is for educational purposes only and is not medical advice. Peptides should only be used under the supervision of a qualified healthcare provider.